Sarepta Therapeutics To Join S&P Midcap 400, Effective June 3
Sarepta Therapeutics To Join S&P Midcap 400, Effective June 3
Sarepta Therapeutics将加入标普中型股400指数，自6月3日起生效
Sarepta Therapeutics will replace Shockwave Medical in the S&P MidCap 400 effective prior to the opening of trading on Monday, June 3. S&P 500 constituent Johnson & Johnson is acquiring Shockwave Medical in a deal expected to be completed soon pending final closing conditions.
Sarepta Therapeutics将在标准普尔中型股400指数中取代Shockwave Medical，该指数将在6月3日星期一开盘前生效。标普500指数成份股公司强生正在收购Shockwave Medical，该交易预计将很快完成，等待最终成交条件。
资讯热榜
更新时间